pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Week of Jul 27, 2026

30
›Jul 31, 20268k filing1d ago$OGN — Organon & Co. (OGN) — 8-K filing

Items: 7.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$VTGN — Vistagen Therapeutics, Inc. (VTGN) — 8-K filing

Items: 5.02, 7.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$NMAD — NOMAD POWER SOLUTIONS, INC. (NMAD) — 8-K filing

Items: 7.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$CODX — Co-Diagnostics, Inc. (CODX) — 8-K filing

Items: 1.01, 3.02, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$XAIR — Beyond Air, Inc. (XAIR) — 8-K filing

Items: 1.01, 3.02, 8.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$SDEV — Stablecoin Development Corp (SDEV) — 8-K filing

Items: 2.02, 7.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$KPTI — Karyopharm Therapeutics Inc. (KPTI) — 8-K filing

Items: 8.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$GCAN — Greater Cannabis Company, Inc. (GCAN) — 8-K filing

Items: 5.02, 5.03, 8.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d agoOSR Health, Inc. (OSRH, OSRHW) — 8-K filing

Items: 7.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$RKTO — Rocket One Inc. (RKTO) — 8-K filing

Items: 8.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$INMB — Inmune Bio, Inc. (INMB) — 8-K filing

Items: 8.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$NBIX — NEUROCRINE BIOSCIENCES INC (NBIX) — 8-K filing

Items: 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d agoSilexion Therapeutics Corp (SLXN, SLXNW) — 8-K filing

Items: 5.02

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$AMGN — AMGEN INC (AMGN) — 8-K filing

Items: 1.05

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$CNTX — Context Therapeutics Inc. (CNTX) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$PDSB — PDS Biotechnology Corp (PDSB) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$AMRX — Amneal Pharmaceuticals, Inc. (AMRX) — 8-K filing

Items: 5.07

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$TRAW — Traws Pharma, Inc. (TRAW) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$EMBC — Embecta Corp. (EMBC) — 8-K filing

Items: 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d agobioAffinity Technologies, Inc. (BIAF, BIAFW) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d agoCalidi Biotherapeutics, Inc. (CLDI, CLDWW) — 8-K filing

Items: 3.03, 5.03, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$MIRA — MIRA PHARMACEUTICALS, INC. (MIRA) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$ATYR — aTYR PHARMA INC (ATYR) — 8-K filing

Items: 1.02, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d agoProfusa, Inc. (PFSA, NVACW) — 8-K filing

Items: 1.01, 3.02, 5.03, 7.01, 8.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$QNCX — Quince Therapeutics, Inc. (QNCX) — 8-K filing

Items: 5.02

full page →edgar 8k ↗
›Jul 31, 20268k filing1d agoGalera Therapeutics, Inc. (GRTX, GRTXD) — 8-K filing

Items: 3.02, 7.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$NWBO — NORTHWEST BIOTHERAPEUTICS INC (NWBO) — 8-K filing

Items: 1.01, 2.03

full page →edgar 8k ↗
›Jul 31, 20268k filing1d agoHumacyte, Inc. (HUMA, HUMAW) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d agoCDT Equity Inc. (CDT, CDTTW) — 8-K filing

Items: 1.01, 3.02, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing1d ago$VTAK — Catheter Precision, Inc. (VTAK) — 8-K filing

Items: 3.02, 3.03, 5.03, 9.01

full page →edgar 8k ↗

Week of Jan 4, 2027

1
›Jan 4, 2027pdufa156dPDUFA — 2027-01-04

action date of January 4, 2027

full page →pdufa extract ↗

Week of Jan 18, 2027

1
›Jan 21, 2027pdufa173dPDUFA — 2027-01-21Ultragenyx Pharmaceutical Inc.

action date of Jan. 21, 2027

full page →pdufa extract ↗

Date TBD

18
›TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗
›TBDapprovalTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →OXCARBAZEPINE →fda approvals ↗
›RECRUITINGphase readoutNCT06924671: GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07542236: Hip and Ankle Mobility Rehabilitation for Soccer Players With Patellofemoral Pain

Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Definium Therapeutics, Inc.

Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06466434: Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06806709: Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07178509: A Study of SCAD Using Stress Contrast EchocardiographyMayo Clinic

Sponsor: Mayo Clinic. Phase: . Conditions: Spontaneous Coronary Artery Dissection

full page →ctgov ↗
›COMPLETEDphase readoutNCT07403409: Scapular Repeated Contractions Facilitation Versus Hold-relax Techniques in Patients With Adhesive Capsulitis

Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06721663: Multisensory Environment Stimulation Therapy on Postural Control in Cerebral Palsy

Sponsor: October 6 University. Phase: NA. Conditions: Cerebral Palsy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06624787: Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Sponsor: Liverpool School of Tropical Medicine. Phase: NA. Conditions: Crimean-Congo Haemorrhagic Fever

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07527221: Safety and Tolerability of ZE74-0282 in Healthy VolunteersCerta Therapeutics Pty Ltd

Sponsor: Eilean Therapeutics AU Pty Ltd. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07329114: Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO)

Sponsor: Chandan Sen. Phase: NA. Conditions: Wound Heal, Wound Infection, Wound Healing Delayed, Wound of Skin, Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT01778504: Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Neuropsychiatric Disorder, Neurological Disorder, Neurodevelopmental Disorder, Sleep

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05103033: Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH)University of Washington

Sponsor: University of Washington. Phase: NA. Conditions: Mental Health Disorder

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06906952: A Prospective Single-center Randomized Controlled Trial of Robotic Surgery With Transrectal Resection Specimens (NOSES-IV) and Traditional Assisted Robotic Surgery for the Treatment of High Rectal and Sigmoid Colon Cancer

Sponsor: Nanchang University. Phase: NA. Conditions: Natural Orifice Specimen Extraction Surgery, Robotic Surgery, Short-term Outcomes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07281547: Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and PainMayo Clinic

Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Endometrial Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07442149: An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005ALUMIS INC.

Sponsor: Alumis Inc. Phase: PHASE1. Conditions: Healthy Volunteer

full page →ctgov ↗
← prev
page 54 of 161
next →
$RARE24.91-4.34%
$ABBV250.94-2.51%
$DFTX
$NVS156.15-1.45%
$ALMS28.25-2.42%